ATI RN
ATI Pharmacology Practice Exam Questions
Question 1 of 5
A client has been prescribed an anticoagulant for atrial fibrillation. Which of the following instructions should the nurse include?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
A client is receiving Morphine IV for pain management. Which of the following actions should the nurse take?
Correct Answer: A
Rationale: The correct action for the nurse is to monitor the client's respiratory rate every 15 minutes while on Morphine IV to promptly detect respiratory depression, a critical adverse effect associated with this medication. Regular monitoring allows for early intervention and prevents potential respiratory complications.
Question 3 of 5
A healthcare professional is reviewing the medication list of a client who has a new prescription for Digoxin to treat heart failure. Which of the following medications places the client at risk for Digoxin toxicity?
Correct Answer: C
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A client is taking Glipizide to treat Diabetes Mellitus. Which of the following laboratory tests should the nurse monitor to evaluate the effectiveness of this medication?
Correct Answer: C
Rationale: Monitoring the client's blood glucose level is essential when taking Glipizide, as it is a medication used to lower blood glucose levels in individuals with Diabetes Mellitus. By monitoring the blood glucose level, the nurse can assess the effectiveness of the medication in managing the client's condition.
Question 5 of 5
A client has a new prescription for radioactive iodine to treat Hyperthyroidism. Which of the following instructions should the nurse include?
Correct Answer: B
Rationale: When a client undergoes radioactive iodine treatment for hyperthyroidism, they can emit radiation for a short time. To prevent radiation exposure to others, especially pregnant women, infants, and small children, clients should avoid close contact for about 1 week following therapy. This precaution is essential to protect vulnerable individuals from potential harm.